Biozone Pharmaceuticals, Inc. (OTCBB:BZNE) Held Down by Selling
Bordering the weekend, selling held down Biozone Pharmaceuticals, Inc. (OTCMKTS:BZNE), the newly active pharmaceutical stock that is yet expected to make a sensation. BZNE slid down more than 11% on Monday, down to $0.755...